Innovative Cancer Treatment Results Announced for Invikafusp Alfa and TRODELVY® at SITC 2026 #United_States #Phoenix #Marengo_Therapeutics #Invikafusp_Alfa #Trodelvy
@newsen.bsky.socialExplore
@newsen.bsky.social@newsen.bsky.socialMarengo Therapeutics Completes Enrollment in Phase 1/2 STARt-001 for Cancer Immunotherapy #USA #Cambridge #Marengo_Therapeutics #Invikafusp_Alfa #STARt-001